. Author manuscript; available in PMC: 2014 Sep 1.

Published in final edited form as: Alcohol Clin Exp Res. 2013 May 3;37(9):1527–1535. doi: 10.1111/acer.12129

Table 1.

Characteristics of adults with HIV infection and current or past alcohol problems

Characteristic	Total study population [n=308]
Males [n (%)]	225 (73.1)

Age (years) [mean (SD)]	42.8 (7.3)

HCV infection (HCV RNA) [n (%)] (n=307)	150 (48.9)

HBsAg positive [n (%)] (n=298)	26 (8.7)

CD4 count [cells/mm³] (n=289)
<200 [n (%)]	54 (18.7)
200–500 [n (%)]	121 (41.9)
>500 [n (%)]	114 (39.4)

HIV RNA viral load [copies/ mL] (n=274)
<1000 [n (%)]	135 (49.3)
≥1000 [n (%)]	139 (50.7)

Body mass index [kg/ m²] (n=293)
<21 [n (%)]	26 (8.9)
21–24 [n (%)]	71 (24.2)
>24 [n (%)]	196 (66.9)

Antiretroviral therapy [n (%)]	186 (60.4)

Lifetime injection drug use [n (%)]	165 (53.7)

Duration of injection-drug use (years) [mean (SD)] (n=307)	11.7 (12.8)

Lifetime alcohol consumption [kg of alcohol] (n=291)
<150 kg [n (%)]	65 (22.3)
150–600 kg [n (%)]	95 (32.7)
>600 kg [n (%)]	131 (45.0)

Heavy episodic drinking [years] (n=301)
<9 years [n (%)]	94 (31.2)
9–21 years [n (%)]	117 (38.9)
>21 years [n (%)]	90 (29.9)

Heavy alcohol use [NIAAA definition] (last 30 days) [n (%)] (n=306)	101 (33.0)

FIB-4
Absence of liver fibrosis (<1.45) [n (%)]	187 (60.7)
Advanced liver fibrosis (>3.25) [n (%)]	31 (10.1)

APRI
Absence of liver fibrosis (<0.5) [n (%)]	178 (57.8)
Advanced liver fibrosis (>1. 5) [n (%)]	28 (9.1)

HCV RNA: Hepatitis C virus Ribonucleic acid; HBsAg: Hepatitis B surface antigen.